Target intelligence / Profile preview

Myxoma virus M013 protein (M013)

Target
M013
Molecular classification
Viral protein, Pyrin-only protein (vPOP), Immunomodulator
01

Overview

The M013 protein is a viral immunomodulatory factor encoded by the Myxoma virus, a member of the Poxviridae family. It functions as a viral pyrin-only protein (vPOP) that effectively subverts the host's innate immune response by targeting two critical signaling pathways: the inflammasome and the NF-kappaB pathway. Specifically, M013 binds directly to the host protein ASC-1 (apoptosis-associated speck-like protein containing a CARD), preventing the assembly of the inflammasome complex and the subsequent activation of caspase-1 and release of pro-inflammatory cytokines like IL-1beta and IL-18. Additionally, it interacts with the NF-kappaB1 (p105) subunit to inhibit NF-kappaB-mediated transcription of inflammatory genes. Due to its potent anti-inflammatory properties, M013 is being investigated as a therapeutic agent, often delivered via viral vectors like AAV, for the treatment of inflammatory and autoimmune conditions such as uveitis and potentially as part of oncolytic virotherapy strategies.

Other names
M013LViral pyrin-only proteinvPOPMyxoma virus M013
02

Biological functions

Immune response modulationInhibition of inflammasome activationInhibition of NF-kappaB signalingApoptosis regulation
03

Disease associations

InflammationAutoimmune diseaseUveitisCancer (Oncolytic virotherapy context)
04

Safety considerations

Potential for systemic immunosuppressionImmunogenicity of the viral protein or delivery vectorOff-target effects on host cell signaling
05

Interacting drugs

AAV-M013 (Gene therapy candidate)

1 more in the full profile.

06

Biomarkers

IL-1beta levelsIL-18 levelsNF-kappaB activation markersCaspase-1 activity

Beyond the preview

Go deeper on Myxoma virus M013 protein (M013).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Myxoma virus M013 protein (M013).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call